期刊
LUPUS
卷 20, 期 2, 页码 206-218出版社
SAGE PUBLICATIONS LTD
DOI: 10.1177/0961203310395803
关键词
anticardiolipin; antiphospholipid; aspirin; hydroxychloroquine; lupus anticoagulant; prevention; stroke; thrombosis; warfarin
类别
资金
- Department of Education, Universities and Research of the Basque Government
The antiphospholipid syndrome (APS) is defined by the presence of thrombosis and/or pregnancy morbidity in combination with the persistent presence of circulating antiphospholipid antibodies: lupus anticoagulant, anticardiolipin antibodies and/or anti-beta 2-glycoprotein I antibodies in medium to high titers. The management of thrombosis in patients with APS is a subject of controversy. This set of recommendations is the result of an effort to produce guidelines for therapy within a group of specialist physicians in Cardiology, Neurology, Hematology, Rheumatology and Internal Medicine, with a clinical and research focus on APS. Lupus (2011) 20, 206-218.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据